Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Eri

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
European Urology|January 1, 1992
Patient recruitment to and cost of a prospective trial of medical treatment for benign prostatic hyperplasiaL M Eri, K J Tveter
European Urology|January 1, 1992
Measuring the quality of life of patients with benign prostatic hyperplasia. Assessment of the usefulness of a new quality of life questionnaire specially adapted to benign prostatic hyperplasia patientsL M Eri, K J Tveter
Drugs & Aging|February 1, 1997
Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspectiveL M Eri, K J Tveter
The Journal of Urology|September 1, 1995
alpha-blockade in the treatment of symptomatic benign prostatic hyperplasiaL M Eri, K J Tveter
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 24, 1999
[Timely screening routines for prostatic cancer by Norwegian physicians]S D Fosså, L M Eri
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 20, 1984
[Inguinal hernia in children. Case material from a central hospital]L M Eri, P A Drabløs
The Journal of Urology|August 1, 1994
Safety, side effects and patient acceptance of the luteinizing hormone releasing hormone agonist leuprolide in treatment of benign prostatic hyperplasiaL M Eri, K J Tveter
The Journal of Urology|August 1, 1993
A prospective, placebo-controlled study of the luteinizing hormone-releasing hormone agonist leuprolide as treatment for patients with benign prostatic hyperplasiaL M Eri, K J Tveter
The Journal of Urology|July 1, 1993
A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasiaL M Eri, K J Tveter
World Journal of Urology|September 12, 2001
The impact of participation in a study of medical treatment of lower urinary tract symptoms on the incidence of prostate surgeryL M Eri, S Sivertsen, J Nagelhus
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
European Urology|January 1, 1992
Patient recruitment to and cost of a prospective trial of medical treatment for benign prostatic hyperplasiaL M Eri, K J Tveter
European Urology|January 1, 1992
Measuring the quality of life of patients with benign prostatic hyperplasia. Assessment of the usefulness of a new quality of life questionnaire specially adapted to benign prostatic hyperplasia patientsL M Eri, K J Tveter
Drugs & Aging|February 1, 1997
Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspectiveL M Eri, K J Tveter
The Journal of Urology|September 1, 1995
alpha-blockade in the treatment of symptomatic benign prostatic hyperplasiaL M Eri, K J Tveter
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 24, 1999
[Timely screening routines for prostatic cancer by Norwegian physicians]S D Fosså, L M Eri
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 20, 1984
[Inguinal hernia in children. Case material from a central hospital]L M Eri, P A Drabløs
The Journal of Urology|August 1, 1994
Safety, side effects and patient acceptance of the luteinizing hormone releasing hormone agonist leuprolide in treatment of benign prostatic hyperplasiaL M Eri, K J Tveter
The Journal of Urology|August 1, 1993
A prospective, placebo-controlled study of the luteinizing hormone-releasing hormone agonist leuprolide as treatment for patients with benign prostatic hyperplasiaL M Eri, K J Tveter
The Journal of Urology|July 1, 1993
A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasiaL M Eri, K J Tveter
World Journal of Urology|September 12, 2001
The impact of participation in a study of medical treatment of lower urinary tract symptoms on the incidence of prostate surgeryL M Eri, S Sivertsen, J Nagelhus
Pageof 4